Effects of Different PICC Catheterization Methods: A Multicenter Randomized Controlled Trial
1 other identifier
interventional
801
1 country
1
Brief Summary
This study aims to compare the clinical effectiveness of three PICC (Peripherally Inserted Central Catheter) insertion methods: conventional non-tunneled PICC, one-needle tunneled PICC, and two-needle tunneled PICC. This is a multicenter randomized controlled trial involving 11 hospitals in China, with a total of 801 patients scheduled to undergo PICC insertion for the first time. Patients will be randomly assigned in a 1:1:1 ratio to the three groups. The primary outcome is the incidence of post-insertion complications (including oozing, infection, thrombosis, catheter dislodgement, etc.) within 90 days. Secondary outcomes include one-time puncture success rate, pain level (NRS), bleeding volume, catheterization time, and unplanned catheter removal rate. The results will provide evidence for selecting the optimal PICC insertion method in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2026
CompletedFirst Posted
Study publicly available on registry
August 28, 2026
CompletedStudy Start
First participant enrolled
September 10, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2027
Study Completion
Last participant's last visit for all outcomes
August 30, 2027
August 28, 2026
August 1, 2026
9 months
August 25, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Incidence of Catheter-Related Complications Within 90 Days Post-catheterization
The composite endpoint includes: oozing/exudation at the catheter exit site, mechanical phlebitis, catheter-related bloodstream infection, local or tunnel infection, catheter-related thrombosis, catheter dislodgement or migration, catheter occlusion, contact dermatitis, and catheter breakage or damage. All complications are assessed from the day of insertion up to 90 days post-insertion.
From catheterization to 90 days post-catheterization
Secondary Outcomes (5)
One-Time Puncture Success Rate
Day 1 During catheterization procedure
Pain Intensity During Catheterization (NRS Score)
Day 1 Immediately after catheterization procedure
Intraoperative Bleeding Volume
Day 1 From start to end of catheterization procedure
Catheterization Procedure Time
Day 1 During catheterization procedure
Unplanned Catheter Removal Rate
From Day 1 catheterization to 90 days post-catheterization
Study Arms (3)
Conventional Non-Tunneled PICC catheterization
ACTIVE COMPARATORPatients receive conventional non-tunneled PICC insertion. The procedure involves ultrasound-guided vein puncture, guidewire insertion, local anesthesia and skin dilation, followed by sheath and catheter advancement. The catheter exit site is at the puncture site.
One-Needle Tunneled PICC catheterization
EXPERIMENTALPatients receive one-needle tunneled PICC insertion. The puncture needle travels subcutaneously for 4 cm before entering the vessel, creating a subcutaneous tunnel. The skin puncture and catheter exit sites are the same. This technique requires only one needle pass for both tunneling and vessel puncture.
Two-Needle Tunneled PICC catheterization
EXPERIMENTALPatients receive two-needle tunneled PICC insertion. Ultrasound-guided vein puncture is performed first, followed by creation of a 4 cm subcutaneous tunnel using a tunneling tool. The puncture site and catheter exit site are separate, with a subcutaneous tunnel connecting them.
Interventions
Ultrasound-guided vein puncture, followed by guidewire insertion, local anesthesia, skin dilation, sheath advancement, and catheter delivery. The catheter exit site is at the puncture site with no subcutaneous tunnel created.
The puncture needle travels subcutaneously for 4 cm before entering the vessel, creating a subcutaneous tunnel with a single needle pass. The puncture site and catheter exit site are the same. This technique combines tunneling and vessel puncture in one step.
A two-step procedure: first, ultrasound-guided vein puncture is performed; then, a separate subcutaneous tunnel of 4 cm is created using a tunneling tool. The puncture site and catheter exit site are separate, connected by a subcutaneous tunnel. The catheter is pulled through the tunnel from the exit site to the puncture site.
Eligibility Criteria
You may qualify if:
- Age 18 to 75 years
- Education level of primary school or above, with adequate reading, writing and --communication skills to independently complete the questionnaire
- First-time PICC insertion using a 4Fr single-lumen solo PICC catheter
- Able to attend follow-up visits at the same hospital for catheter maintenance after insertion
- Willing to participate in the study and sign the informed consent form and PICC insertion consent form
You may not qualify if:
- Coagulation dysfunction (INR \> 1.5 or PLT \< 25 × 10⁹/L)
- Use of anticoagulants (e.g., warfarin, heparin) within 3 days before catheterization
- Pregnant or lactating women
- BMI \< 18.5 kg/m²
- Patients requiring lower extremity PICC insertion
- Known or suspected allergy to components of the PICC catheter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sun Yat-sen Universitylead
- Gansu Hospital of Sun Yat-sen University Cancer Centercollaborator
- Shenzhen People's Hospitalcollaborator
- Zhongshan People's Hospital, Guangdong, Chinacollaborator
- First Affiliated Hospital of Jinan Universitycollaborator
- Haikou People's Hospitalcollaborator
- The First Affiliated Hospital of Nanchang Universitycollaborator
- Jiangsu Cancer Institute & Hospitalcollaborator
- Wuzhou Red Cross Hospitalcollaborator
- Renmin Hospital of Wuhan Universitycollaborator
- Jieyang People's Hospitalcollaborator
Study Sites (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510000, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- specialist nurse
Study Record Dates
First Submitted
August 25, 2026
First Posted
August 28, 2026
Study Start (Estimated)
September 10, 2026
Primary Completion (Estimated)
May 30, 2027
Study Completion (Estimated)
August 30, 2027
Last Updated
August 28, 2026
Record last verified: 2026-08